Recently developed PD-L1-overexpressed MSC-EVs significantly suppress pathogenic immune responses via the PD1/PD-L1 pathway in two different autoimmune diseases: ulcerative colitis and psoriasis [64]. The gene discussed is SNCA; the disease is autoimmune disease.